Ovarian cancer is characterize by few early symptoms, presentation at an advanced stage,
and poor survival. As a result, it is the most frequent cause of death from gynecological …

A variety of biomarkers have been developed to monitor growth of ovarian cancer and to
detect disease at an early interval. CA125 (MUC16) has provided a useful serum tumor …

DNA microarray technology has led to an explosion of oncogenomic analyses, generating a
wealth of data and uncovering the complex gene expression patterns of cancer …

Abstract Background: Updated National Academy of Clinical Biochemistry (NACB)
Laboratory Medicine Practice Guidelines for the use of tumor markers in the clinic have been …

Early detection remains the most promising approach to improve long-term survival of
patients with ovarian cancer. In a five-center case-control study, serum proteomic …

Genetic alterations in tumor cells often lead to the emergence of growth-stimulatory
autocrine and paracrine signals, involving overexpression of secreted peptide growth …

Early detection of ovarian cancer has been a challenge to manage the high mortality rate
caused by this deadly disease. The trends in mortality have been reduced by the scientific …

Purpose: Advanced-stage epithelial ovarian cancer has a poor prognosis with long-term
survival in less than 30% of patients. When the disease is detected in stage I, more than …

Ovarian cancer is a silent cancer which rate survival mainly relays in early stage detection.
The discovery of reliable ovarian cancer biomarkers plays a crucial role in the disease …

Ovarian cancer is the eighth-most common cause of death among women worldwide. In the
absence of distinctive symptoms in the early stages, the majority of women are diagnosed in …